Analysts expect Centene Corp (NYSE:CNC) to announce earnings per share (EPS) of $1.24 for the current quarter, Zacks reports. Five analysts have issued estimates for Centene’s earnings, with the lowest EPS estimate coming in at $1.03 and the highest estimate coming in at $1.37. Centene reported earnings of $1.39 per share during the same quarter last year, which suggests a negative year over year growth rate of 10.8%. The firm is scheduled to announce its next quarterly earnings report on Tuesday, April 28th.
On average, analysts expect that Centene will report full-year earnings of $4.81 per share for the current financial year, with EPS estimates ranging from $4.75 to $4.96. For the next fiscal year, analysts anticipate that the business will post earnings of $5.79 per share, with EPS estimates ranging from $5.61 to $6.05. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research firms that that provide coverage for Centene.
Centene (NYSE:CNC) last posted its quarterly earnings data on Tuesday, February 4th. The company reported $0.73 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.73. Centene had a net margin of 1.77% and a return on equity of 15.18%. The business had revenue of $18.86 billion for the quarter, compared to analyst estimates of $18.45 billion. During the same quarter last year, the business earned $0.69 earnings per share. The business’s revenue for the quarter was up 13.9% on a year-over-year basis.
NYSE CNC opened at $64.94 on Friday. Centene has a 12 month low of $41.62 and a 12 month high of $68.64. The company has a debt-to-equity ratio of 1.08, a current ratio of 1.57 and a quick ratio of 1.01. The firm has a market capitalization of $26.87 billion, a PE ratio of 20.68, a P/E/G ratio of 0.99 and a beta of 0.95. The company’s 50 day simple moving average is $64.01 and its 200 day simple moving average is $54.29.
In other Centene news, EVP Jesse N. Hunter sold 20,000 shares of Centene stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $60.00, for a total value of $1,200,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Robert K. Ditmore sold 30,000 shares of Centene stock in a transaction that occurred on Thursday, February 6th. The stock was sold at an average price of $65.31, for a total transaction of $1,959,300.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 191,500 shares of company stock worth $11,648,920. 2.50% of the stock is currently owned by company insiders.
A number of institutional investors have recently bought and sold shares of the business. Captrust Financial Advisors grew its position in Centene by 5,219.4% during the 4th quarter. Captrust Financial Advisors now owns 10,426 shares of the company’s stock worth $645,000 after purchasing an additional 10,230 shares in the last quarter. Orion Portfolio Solutions LLC purchased a new position in Centene during the 4th quarter worth approximately $67,000. Castleark Management LLC acquired a new stake in shares of Centene during the 4th quarter valued at $421,000. Partner Investment Management L.P. acquired a new stake in shares of Centene during the 4th quarter valued at $430,000. Finally, Partner Fund Management L.P. acquired a new stake in shares of Centene during the 4th quarter valued at $51,505,000. Hedge funds and other institutional investors own 97.59% of the company’s stock.
Centene Company Profile
Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. The company's Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which covers dually eligible individuals, as well as aged, blind, or disabled programs.
Further Reading: What is FinTech?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.